A new Treasury Department proposal would restrict U.S. investments in Chinese biotechs, but still allows licensing deals.
Bristol Myers Squibb on Friday reported that one patient died after receiving its investigational CAR-T therapy in an early ...
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, ...
The humbling truth is that forces outside medical care and public health policies must be playing the biggest role in a ...
It seems everyone has a hot take on the new Elizabeth Holmes documentary, "You Can See Everything." STAT reporters went to ...
As a Boston judge heard a challenge to Medicaid work requirements, state Medicaid directors gathered in Maryland to figure ...
A lung cancer patient speaks out about her cutting-edge treatment: “Research is big on tracking survival stats, but quality ...
What state officials scrambling to implement Medicaid work requirements shared behind closed doors at the National ...
A Moderna and Merck personalized mRNA cancer vaccine reduced the risk of disease recurrence in patients with melanoma by 42% ...
It’s yet to be seen whether Alnylam’s drug will actually slow progression of Huntington’s, but the field is lively.
Rumors are swirling that the Treasury Department this week is going to propose a rule that restricts U.S. investment in the ...
Speaking on the economy, the vice president told a crowd in Ohio that, “You don’t turn the Titanic around overnight.” Send ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results